Free Trial

Lyra Therapeutics (LYRA) News Today

Lyra Therapeutics logo
$0.18 -0.02 (-10.10%)
(As of 11/20/2024 ET)
William Blair Analysts Increase Earnings Estimates for LYRA
What is HC Wainwright's Forecast for LYRA FY2024 Earnings?
Lyra Therapeutics, Inc. (LYRA)
Where Lyra Therapeutics Stands With Analysts
Lyra Therapeutics, Inc. stock logo
Lyra Therapeutics (NASDAQ:LYRA) Cut to "Neutral" at HC Wainwright
HC Wainwright downgraded shares of Lyra Therapeutics from a "buy" rating to a "neutral" rating and lowered their price objective for the company from $12.00 to $2.00 in a research report on Tuesday.
Lyra Therapeutics, Inc. stock logo
Q2 2024 EPS Estimates for Lyra Therapeutics, Inc. (NASDAQ:LYRA) Decreased by Analyst
Lyra Therapeutics, Inc. (NASDAQ:LYRA - Free Report) - Analysts at HC Wainwright reduced their Q2 2024 EPS estimates for Lyra Therapeutics in a research report issued to clients and investors on Wednesday, May 1st. HC Wainwright analyst M. Caufield now anticipates that the company will post earnin
Lyra Therapeutics, Inc. stock logo
Lyra Therapeutics' (LYRA) "Buy" Rating Reiterated at HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $12.00 price objective on shares of Lyra Therapeutics in a research report on Wednesday.
Lyra Therapeutics, Inc. stock logo
Lyra Therapeutics (NASDAQ:LYRA) Price Target Cut to $11.00
Bank of America decreased their price target on shares of Lyra Therapeutics from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Monday.
Lyra Therapeutics, Inc. stock logo
Lyra Therapeutics (NASDAQ:LYRA) Receives "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $12.00 price objective on shares of Lyra Therapeutics in a research report on Friday.
Lyra Therapeutics, Inc. stock logo
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Short Interest Down 13.6% in February
Lyra Therapeutics, Inc. (NASDAQ:LYRA - Get Free Report) was the target of a significant decline in short interest during the month of February. As of February 29th, there was short interest totalling 160,200 shares, a decline of 13.6% from the February 14th total of 185,400 shares. Based on an average daily trading volume, of 254,600 shares, the days-to-cover ratio is currently 0.6 days.
LYRA Jul 2024 2.500 call
LYRA Jul 2024 7.500 call
LYRA Apr 2024 7.500 put
Get Lyra Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LYRA and its competitors with MarketBeat's FREE daily newsletter.

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

LYRA Media Mentions By Week

LYRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LYRA
News Sentiment

0.65

0.45

Average
Medical
News Sentiment

LYRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LYRA Articles
This Week

10

1

LYRA Articles
Average Week

Get Lyra Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LYRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LYRA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners